UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Targeting macrophages rescues age‐related immune deficiencies in C57BL/6J geriatric mice

Aging cell, 2013-06, Vol.12 (3), p.345-357

2013

Volltextzugriff (PDF)

Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration

PloS one, 2013-08, Vol.8 (8), p.e73684-e73684

2013

Volltextzugriff (PDF)

The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model

Frontiers in immunology, 2022-11, Vol.13, p.969678-969678

2022

Volltextzugriff (PDF)

Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function

PloS one, 2015-04, Vol.10 (4), p.e0123563

2015

Volltextzugriff (PDF)

Prognostic role of immune environment in luminal B early breast cancer

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8278-8288

2023

Volltextzugriff (PDF)

Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation

PloS one, 2018-04, Vol.13 (4), p.e0195313-e0195313

2018

Volltextzugriff (PDF)

Aging Leads to Increased Monocytes and Macrophages With Altered CSF-1 Receptor Expression and Earlier Tumor-Associated Macrophage Expansion in Murine Mesothelioma

Frontiers in aging, 2022-04, Vol.3, p.848925-848925

2022

Volltextzugriff (PDF)

Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia

Frontiers in genetics, 2018-11, Vol.9, p.526-526

2018

Volltextzugriff (PDF)

Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model

Frontiers in immunology, 2020-01, Vol.10, p.3074-3074

2020

Volltextzugriff (PDF)

CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy

Oncoimmunology, 2019-04, Vol.8 (4), p.e1564452

2019

Volltextzugriff (PDF)

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site

International immunology, 2008-11, Vol.20 (11), p.1467-1479

2008

Volltextzugriff (PDF)

A review of the importance of immune responses in luminal B breast cancer

Oncoimmunology, 2017-03, Vol.6 (3), p.e1282590-e1282590

2017

Volltextzugriff (PDF)

Turning the tumor microenvironment into a self vaccine site

Oncoimmunology, 2012-09, Vol.1 (6), p.989-991

Nelson, Delia J.

2012

Volltextzugriff (PDF)

Aging and cancer: The role of macrophages and neutrophils

Ageing research reviews, 2017-07, Vol.36, p.105-116

2017

Volltextzugriff (PDF)

IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase

International immunology, 2012-06, Vol.24 (6), p.357-368

2012

Volltextzugriff (PDF)

Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?

Experimental gerontology, 2014-06, Vol.54, p.53-57

2014

Volltextzugriff (PDF)

The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy

Frontiers in medicine, 2018-11, Vol.5, p.337-337

2018

Volltextzugriff (PDF)

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo

Cancer Immunology, Immunotherapy, 2012-12, Vol.61 (12), p.2343-2356

2012

Volltextzugriff (PDF)

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses

Cancer Immunology, Immunotherapy, 2012-04, Vol.61 (4), p.549-560

2012

Volltextzugriff (PDF)

Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules

Ageing research reviews, 2017-09, Vol.38, p.40-51

2017

Volltextzugriff (PDF)

Photophysical and biological investigation of phenol substituted rhenium tetrazolato complexes

Dalton transactions : an international journal of inorganic chemistry, 2019-11, Vol.48 (41), p.15613-15624

2019

Volltextzugriff (PDF)

Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T‐ and B‐cell zones

Immunology and cell biology, 2018-09, Vol.96 (8), p.831-840

2018

Volltextzugriff (PDF)

Murine mesothelioma induces locally-proliferating IL-10+TNF-α+CD206−CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy

Oncoimmunology, 2016-06, Vol.5 (6), p.e1173299-e1173299

2016

Volltextzugriff (PDF)

The use of agonistic anti-CD40 therapy in treatments for cancer

International reviews of immunology, 2012-08, Vol.31 (4), p.246

2012

Volltextzugriff (PDF)

Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective "Arming" of Tumor Antigen-Specific CTL

The Journal of immunology (1950), 2001-05, Vol.166 (9), p.5557-5566

2001

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(75)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting macrophages rescues age‐related immune deficiencies in C57BL/6J geriatric mice

Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration

The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model

Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function

Prognostic role of immune environment in luminal B early breast cancer

Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation

Aging Leads to Increased Monocytes and Macrophages With Altered CSF-1 Receptor Expression and Earlier Tumor-Associated Macrophage Expansion in Murine Mesothelioma

Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia

Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model

CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site

A review of the importance of immune responses in luminal B breast cancer

Turning the tumor microenvironment into a self vaccine site

Aging and cancer: The role of macrophages and neutrophils

IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase

Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?

The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses

Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules

Photophysical and biological investigation of phenol substituted rhenium tetrazolato complexes

Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T‐ and B‐cell zones

Murine mesothelioma induces locally-proliferating IL-10+TNF-α+CD206−CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy

The use of agonistic anti-CD40 therapy in treatments for cancer

Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective "Arming" of Tumor Antigen-Specific CTL

Suchergebnisse filtern